Erin Michael is a Senior Editorial Features Manager at Healio. She specializes in medicine and healthcare, with a focus on topics such as oncology, immunotherapy, palliative care, and hematology, while also delving into data and analytics within the health and wellness sector. Erin's work has been featured in Macaroni KID and Healio.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Erin Michael's articles primarily cover healthcare and pharmaceutical topics, with a significant emphasis on citing data. This suggests she would be interested in pitches based on robust scientific research or data-driven insights. Given her focus, pitching experts who are actively involved in medical research or practitioners with experience applying the latest innovations could be particularly effective.
As her coverage includes industry-specific content and expert commentary, consider offering access to professionals capable of providing nuanced analysis of medical advancements or technological innovations within the healthcare and pharmaceutical sectors.
While Erin's geographic focus is not specified, it seems that she covers global developments in healthcare and pharmaceuticals without specific regional constraints.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Michael Stewart, Erin Michael, Christine Klimanskis
ORLANDO — In this video from the American Academy of Ophthalmology meeting, Michael W. Stewart, MD, discussed results from the phase 2 DAVIO 2 trial on Duravyu in neovascular age-related macular degeneration.
By: Christine Klimanskis, Erin Michael, Michael Stewart
Video Player is loading. Play Video Play Mute Current Time Duration Loaded Stream Type
By: Carol L. DiBerardino, Raj Chovatiya, Erin Michael
Video Player is loading. Play Video Play Mute Current Time Duration Loaded Stream Type LIVE
By: Raj Chovatiya, Carol L. DiBerardino, Erin Michael
Video Player is loading. Play Video Play Mute Current Time Duration Loaded Stream Type LIVE
By: Christopher Lock, Erin Michael
Video Player is loading. Play Video Play Mute Current Time Duration Loaded Stream Type LIVE
In this Healio video, Christopher Lock, MD, discusses advances in Alzheimer’s disease treatment and diagnosis presented at the 2026 American Academy of Neurology Annual Meeting.
By: Christopher Lock, Erin Michael
Video Player is loading. Play Video Play Mute Current Time Duration Loaded Stream Type LIVE
By: Shenaz Bagha, Christopher Lock, Erin Michael
Video Player is loading. Play Video Play Mute Current Time Duration Loaded Stream Type LIVE
By: Cristian Lasagna-Reeves Phd, Erin Michael
In this Healio interview, Cristian Lasagna-Reeves, PhD, discusses findings from a study that showed older adults with high levels of p-tau217 were more likely to develop Alzheimer’s disease over 10 years.
By: Erin Michael, Cristian Lasagna-Reeves Phd
Cristian Lasagna-Reeves, PhD, spoke with Healio about results from the LatAm-FINGERS study presented at this year’s Alzheimer’s Association International Conference.
